Fundz

Flare Therapeutics Appoints Douglas Manion as Chief Executive Officer

PRIVATEApr 23, 2024

Position

Chief Executive Officer

Company

Flare Therapeutics

Douglas Manion
dmanion@flaretx.com
CambridgeBiotechnologyHealth CareTherapeutics

Description

Flare Therapeutics Inc. announced the appointment of Douglas Manion, M.D., FRCP (C), as Chief Executive Officer, effective immediately. Dr

Quick answer

Flare Therapeutics Appoints Douglas Manion as Chief Executive Officer (April 23, 2024). Flare Therapeutics is based in Cambridge, Massachusetts, United States.

Who is the new Chief Executive Officer at Flare Therapeutics?
Flare Therapeutics named Douglas Manion Chief Executive Officer, announced April 23, 2024.
What did Flare Therapeutics announce on April 23, 2024?
Flare Therapeutics Inc. announced the appointment of Douglas Manion, M.D., FRCP (C), as Chief Executive Officer, effective immediately.
What does Flare Therapeutics do?
Flare Therapeutics is a biotechnology company exclusively focused on drugging transcription factors (TFs) to fully unlock the therapeutic potential of this previously elusive target class.
Where is Flare Therapeutics based?
Flare Therapeutics is based in Cambridge, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Actym Therapeutics (April 24, 2024), Arvinas (April 24, 2024), Artiva Biotherapeutics (April 25, 2024) and Recursion Pharmaceuticals (April 19, 2024) also announced leadership changes within 45 days of Flare Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Flare Therapeutics, and when

A new leader at Flare Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Flare Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Flare Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Flare Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Flare Therapeutics

Location

Cambridge, Massachusetts, United States

About

Flare Therapeutics is a biotechnology company exclusively focused on drugging transcription factors (TFs) to fully unlock the therapeutic potential of this previously elusive target class. Flare Therapeutics' integrated discovery engine converges rich genetic, biochemical, and chemical insights to reveal druggable pockets and identify small molecule ligands capable of modulating TFs of high therapeutic potential. Flare Therapeutics' proteomic and mass spectrometry platform is powered by a proprietary library of electrophilic compounds unique to Flare Therapeutics. The team has rapidly established an emerging pipeline of programs, highlighted by FX-909, a first-in-class investigational orally bioavailable small molecule inhibitor of PPARG, a master regulator of the luminal lineage in advanced urothelial cancer that is currently in a Phase I study. For more information, please visit www.flaretx.com and follow us on LinkedIn.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Flare Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Amit
Likely contact at this company
••••••••@••••••••

See Amit's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Flare Therapeutics's next move

Learn about Strategic plan

Flare Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.